Featured Research

from universities, journals, and other organizations

Fighting flu in newborns begins in pregnancy, study suggests

Date:
December 20, 2010
Source:
Yale University
Summary:
A three-year study has found that vaccinating pregnant women against influenza is over 90 percent effective in preventing their infants from being hospitalized with influenza in the first six months of life.

A three-year study by Yale School of Medicine researchers has found that vaccinating pregnant women against influenza is over 90 percent effective in preventing their infants from being hospitalized with influenza in the first six months of life. Published in the December 15 issue of Clinical Infectious Diseases, the study builds on preliminary data the research team presented last year at the Infectious Disease Society of America in Philadelphia.

Influenza is a major cause of serious respiratory disease in pregnant women and of hospitalization in infants. Although the flu vaccine is recommended for all pregnant women and children, no vaccine is approved for infants under six months of age. Preventive strategies for this age group include general infection control and vaccination of those coming in close contact with them.

First author Isaac Benowitz, a Yale medical student, senior author Marietta Vazquez, M.D., and their colleagues examined the effectiveness of flu vaccine during pregnancy in preventing hospitalization in infants. The study enrolled infants hospitalized at Yale-New Haven Hospital due to influenza and a similar group of infants without influenza. The researchers then compared whether each infant's mother had gotten the flu vaccine during pregnancy.

"When we compared vaccination rates during pregnancy in the study, we found that in the group of infants who didn't have influenza, far more mothers received the influenza vaccine," said Vazquez, assistant professor in the Department of Pediatrics at Yale. "In the group of infants studied, giving the vaccine to a woman during pregnancy was 91.5 percent effective in preventing hospitalization due to influenza."

Vazquez said that the study's findings provide an effective strategy for protecting infants under six months old, for whom no vaccine is available. She also points out that vaccination during pregnancy is cost-effective, as one vaccine protects two individuals.

Other Yale authors on the study include Daina B. Esposito, Kristina D. Gracey and Eugene D. Shapiro, M.D.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Isaac Benowitz, Daina B. Esposito, Kristina D. Gracey, Eugene D. Shapiro, Marietta Vázquez. Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their Infants. Clinical Infectious Diseases, 2010; 51 (12): 1355 DOI: 10.1086/657309

Cite This Page:

Yale University. "Fighting flu in newborns begins in pregnancy, study suggests." ScienceDaily. ScienceDaily, 20 December 2010. <www.sciencedaily.com/releases/2010/12/101214151927.htm>.
Yale University. (2010, December 20). Fighting flu in newborns begins in pregnancy, study suggests. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/12/101214151927.htm
Yale University. "Fighting flu in newborns begins in pregnancy, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/12/101214151927.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins